Active substance
Meloxicam
- SFDA 28
- US FDA 32
- Health Canada 10
- US price lines 4
- NHS prices 4
- Safety 7
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| COXICAM | 7.5 mg | Tablet · Oral use | 30 Blister | SAR 24.30 | Generic · Prescription | RIYADH PHARMA | Valid |
| COXICAM | 7.5 mg | Tablet · Oral use | 10 Blister | SAR 10.85 | Generic · Prescription | RIYADH PHARMA | Valid |
| COXICAM | 15 mg | Tablet · Oral use | 10 Blister | SAR 13.30 | Generic · Prescription | RIYADH PHARMA | Valid |
| MOBIC 15MG TAB | 15 mg | Tablet · Oral use | 30 Blister | SAR 44.45 | NCE · Prescription | BOEHRINGER INGELHEIM | Valid |
| MOBIC 7.5MG TAB | 7.5 mg | Tablet · Oral use | 30 Tablet Container | SAR 27.00 | NCE · Prescription | BOEHRINGER INGELHEIM | Valid |
| MOVEN 15MG CAPSULE | 15 mg | Capsule, hard · Oral use | 30 Blister | SAR 35.90 | Generic · Prescription | THE ARAB PHARMACEUTICAL MANUFACTURING PSC (SAHAB) | Valid |
| MOVEN 15MG CAPSULE | 15 mg | Capsule, hard · Oral use | 10 Blister | SAR 14.10 | Generic · Prescription | THE ARAB PHARMACEUTICAL MANUFACTURING PSC (SAHAB) | Valid |
| MOVEN 7.5MG CAPSULE | 7.5 mg | Capsule, hard · Oral use | 30 Blister | SAR 21.85 | Generic · Prescription | THE ARAB PHARMACEUTICAL MANUFACTURING PSC (SAHAB) | Valid |
| MOVEN 7.5MG CAPSULE | 7.5 mg | Capsule, hard · Oral use | 10 Blister | SAR 9.65 | Generic · Prescription | THE ARAB PHARMACEUTICAL MANUFACTURING PSC (SAHAB) | Valid |
| Melocam | 15 mg | Tablet · Oral use | 15 Blister | SAR 37.80 | Generic · Prescription | SAUDI PHARMACEUTICAL INDUSTRIES | Valid |
| Melocam | 7.5 mg | Tablet · Oral use | 30 Blister | SAR 22.95 | Generic · Prescription | SAUDI PHARMACEUTICAL INDUSTRIES | Valid |
| OXIMAL 15MG TABLETS | 15 mg | Tablet · Oral use | 10 Blister | SAR 9.90 | Generic · Prescription | The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM) | Valid |
| OXIMAL 15MG TABLETS | 15 mg | Tablet · Oral use | 30 Blister | SAR 29.75 | Generic · Prescription | The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM) | Valid |
| OXIMAL 7.5MG TABLETS | 7.5 mg | Tablet · Oral use | 30 Blister | SAR 19.65 | Generic · Prescription | The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM) | Valid |
| OXIMAL 7.5MG TABLETS | 7.5 mg | Tablet · Oral use | 10 Blister | SAR 8.70 | Generic · Prescription | The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM) | Valid |
| SELEKTINE | 15 mg | Tablet · Oral use | 30 Blister | SAR 18.00 | Generic · Prescription | HAYAT PHARMACEUTICAL INDUSTRIES | Valid |
| SELEKTINE | 7.5 mg | Tablet · Oral use | 30 Blister | SAR 11.95 | Generic · Prescription | HAYAT PHARMACEUTICAL INDUSTRIES | Valid |
| NEOXICAM 15MG TABLETS | 15 mg | Tablet · Oral use | 10 Blister | SAR 7.75 | Generic · Prescription | NEOPHARMA | Suspended |
| NEOXICAM 7.5MG TABLETS | 7.5 mg | Tablet · Oral use | 10 Blister | SAR 5.15 | Generic · Prescription | NEOPHARMA | Suspended |
| MELOXI 15 MG TABLETS | 15 mg | Tablet · Oral use | 30 Blister | SAR 20.90 | Generic · Prescription | Jamjoom Pharmaceuticals Factory Company | Withdrawn by MAH · Not Marketed |
| MELOXI 7.5 MG TABLETS | 7.5 mg | Tablet · Oral use | 30 Blister | SAR 13.90 | Generic · Prescription | Jamjoom Pharmaceuticals Factory Company | Withdrawn by MAH · Not Marketed |
| MELOXYDAR 15MG TABLETS | 15 mg | Tablet · Oral use | 30 Blister | SAR 16.20 | Generic · Prescription | DAR ALDAWA | Withdrawn by MAH · Not Marketed |
| MELOXYDAR 15MG TABLETS | 15 mg | Tablet · Oral use | 10 Blister | SAR 5.40 | Generic · Prescription | DAR ALDAWA | Withdrawn by MAH · Not Marketed |
| MELOXYDAR 7.5MG TABLETS | 7.5 mg | Tablet · Oral use | 10 Blister | SAR 3.60 | Generic · Prescription | DAR ALDAWA | Withdrawn by MAH · Not Marketed |
| MELOXYDAR 7.5MG TABLETS | 7.5 mg | Tablet · Oral use | 30 Blister | SAR 10.80 | Generic · Prescription | DAR ALDAWA | Withdrawn by MAH · Not Marketed |
3 more — full table
Indications — CHI Daman Drug Formulary
ANKYLOSING SPONDYLITIS; ENDOMETRIOSIS; ENTEROPATHIC ARTHROPATHIES, UNSPECIFIED SITE REACTIVE ARTHROPATHY, UNSPECIFIED; JUVENILE IDIOPATHIC ARTHRITIS (JIA); LOW BACK PAIN; MENSTRUAL DISORDERS; MUCOSAL ULCERATION-SUPPORTIVE AGENTS; NON-INFECTIOUS UVEITIS; OSTEOARTHRITIS; PAIN MANAGEMENT IN CANCER PATIENTS; POSTOPERATIVE PAIN; PSORIATIC ARTHRITIS; RENAL AND URETERIC STONES; RHEUMATOID ARITHRITIS
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| MELOXICAM | 7.5MG/5ML | suspension · oral | AVONDALE PHARMS | Prescription | 1 Jun 2004 |
| MELOXICAM | 7.5MG; 15MG | tablet · oral | AIPING PHARM INC | Prescription | 19 Jul 2006 |
| MELOXICAM | 7.5MG; 15MG | tablet · oral | ZYDUS PHARMS USA | Prescription | 19 Jul 2006 |
| MELOXICAM | 7.5MG; 15MG | tablet · oral | CIPLA | Prescription | 19 Jul 2006 |
| MELOXICAM | 7.5MG; 15MG | tablet · oral | GLENMARK PHARMS LTD | Prescription | 19 Jul 2006 |
| MELOXICAM | 7.5MG; 15MG | tablet · oral | PURACAP PHARM | Prescription | 19 Jul 2006 |
| MELOXICAM | 7.5MG; 15MG | tablet · oral | COREPHARMA | Prescription | 20 Jul 2006 |
| MELOXICAM | 7.5MG; 15MG | tablet · oral | RISING | Prescription | 25 Jul 2006 |
| MELOXICAM | 7.5MG; 15MG | tablet · oral | AUROBINDO PHARMA | Prescription | 2 Oct 2006 |
| MELOXICAM | 7.5MG; 15MG | tablet · oral | YUNG SHIN PHARM | Prescription | 7 Dec 2006 |
| MELOXICAM | 7.5MG; 15MG | tablet · oral | UNICHEM | Prescription | 20 Dec 2006 |
| MELOXICAM | 7.5MG; 15MG | tablet · oral | NOVITIUM PHARMA | Prescription | 13 May 2009 |
| MELOXICAM | 5MG; 10MG | capsule · oral | LUPIN | Prescription | 1 Jun 2020 |
| MELOXICAM | 5MG; 10MG | capsule · oral | NOVITIUM PHARMA | Prescription | 9 Mar 2021 |
| MELOXICAM | 7.5MG; 15MG | tablet · oral | ASCENT PHARMS INC | Prescription | 7 Jun 2023 |
| QAMZOVA | 30MG/ML (30MG/ML) | solution · intravenous | NANJING DELOVA | Prescription | 22 Apr 2025 |
| XIFYRM | 30MG/ML (30MG/ML) | solution · intravenous | AZURITY | Prescription | 5 Jun 2025 |
| MOBIC | 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | BOEHRINGER INGELHEIM | Discontinued | 13 Apr 2000 |
| MELOXICAM | 7.5MG; 15MG | tablet · oral | NATCO PHARMA | Discontinued | 19 Jul 2006 |
| MELOXICAM | 7.5MG; 15MG | tablet · oral | ROXANE | Discontinued | 19 Jul 2006 |
| MELOXICAM | 7.5MG; 15MG | tablet · oral | IMPAX LABS INC | Discontinued | 19 Jul 2006 |
| MELOXICAM | 7.5MG; 15MG | tablet · oral | ZENNOVA | Discontinued | 19 Jul 2006 |
| MELOXICAM | 7.5MG; 15MG | tablet · oral | TP ANDA HOLDINGS | Discontinued | 19 Jul 2006 |
| MELOXICAM | 7.5MG; 15MG | tablet · oral | CHARTWELL RX | Discontinued | 19 Jul 2006 |
| MELOXICAM | 7.5MG; 15MG | tablet · oral | SUN PHARM INDS INC | Discontinued | 19 Jul 2006 |
7 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| APO-MELOXICAM | 02248973 | 7.5 MG | TABLET · ORAL | APOTEX INC |
| APO-MELOXICAM | 02248974 | 15 MG | TABLET · ORAL | APOTEX INC |
| AURO-MELOXICAM | 02390884 | 7.5 MG | TABLET · ORAL | AURO PHARMA INC |
| AURO-MELOXICAM | 02390892 | 15 MG | TABLET · ORAL | AURO PHARMA INC |
| MELOXICAM | 02353148 | 7.5 MG | TABLET · ORAL | SANIS HEALTH INC |
| MELOXICAM | 02353156 | 15 MG | TABLET · ORAL | SANIS HEALTH INC |
| PMS-MELOXICAM | 02248267 | 7.5 MG | TABLET · ORAL | PHARMASCIENCE INC |
| PMS-MELOXICAM | 02248268 | 15 MG | TABLET · ORAL | PHARMASCIENCE INC |
| TEVA-MELOXICAM | 02258315 | 7.5 MG | TABLET · ORAL | TEVA CANADA LIMITED |
| TEVA-MELOXICAM | 02258323 | 15 MG | TABLET · ORAL | TEVA CANADA LIMITED |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | MELOXICAM 10 MG CAPSULE | $11.24632 | per EA | 23 Sep 2026 |
| US NADAC | MELOXICAM 15 MG TABLET | $0.01842 | per EA | 23 Sep 2026 |
| US NADAC | MELOXICAM 5 MG CAPSULE | $8.92251 | per EA | 23 Sep 2026 |
| US NADAC | MELOXICAM 7.5 MG TABLET | $0.01657 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Meloxicam 15mg orodispersible tablets sugar free | £49.99 | 30 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Meloxicam 15mg tablets | £0.64 | 30 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Meloxicam 7.5mg orodispersible tablets sugar free | £49.99 | 30 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Meloxicam 7.5mg tablets | £0.78 | 30 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- US FDA 21 Nov 2024 MOBIC — safety-related labeling change
Labeling sections changed: Boxed Warning; Warnings and Precautions; Adverse Reactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - US FDA 21 Nov 2024 MELOXICAM — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions - US FDA 21 Nov 2024 VIVLODEX — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - US FDA 21 Nov 2024 ZYNRELEF KIT — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions; Use in Specific Populations - US FDA 28 Apr 2021 MOBIC — safety-related labeling change
Labeling sections changed: Boxed Warning; Warnings and Precautions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - US FDA 28 Apr 2021 ANJESO — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - US FDA 28 Apr 2021 QMIIZ ODT — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide
Combinations containing Meloxicam
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.